LabCompass

Nasser H. Hanna

Medicine · Indiana University

OpenAlex ORCID
Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentTesticular diseases and treatmentsCancer Immunotherapy and Biomarkers

Publications

468

Citations

16,602

Est. group size

~4

Recurring co-author estimate

Active years

48

Publishing since 1979

Research summary
AI-generated

Nasser H. Hanna conducts clinical research on the treatment of lung cancer, especially non-small cell and small cell lung cancer. His work includes clinical trials testing chemotherapy, immunotherapy, and combination drug regimens, as well as studies on cancer screening, treatment guidelines, and patient care factors. Much of this research is carried out through multi-institutional clinical trial consortia.

Non-small cell lung cancer treatmentSmall cell lung cancer clinical trialsCancer immunotherapy (immune checkpoint inhibitors)Lung cancer screening and early detectionTreatment guidelines and patient care factors

Publication activity has been relatively steady but shows a gradual decline in recent years, dropping from around 20-35 papers per year earlier in the decade to roughly 12-18 more recently.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 14.2/year recently
2017: 29 publications172018: 21 publications182019: 20 publications192020: 35 publications35202021: 29 publications212022: 20 publications222023: 20 publications232024: 18 publications242025: 12 publications252026: 1 publication26
Recent publications
Publishes in
  • Journal of Clinical Oncology×101
  • Journal of Thoracic Oncology×11
  • Clinical Lung Cancer×8
  • Cancer×5
  • Clinical Genitourinary Cancer×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile